These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6860251)

  • 21. Phenylketonuria in a patient with cystinuria.
    Minami R; Olek K; Wardenbach P
    Humangenetik; 1975 Aug; 28(4):319-24. PubMed ID: 1176121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of genotype and intellectual phenotype in untreated phenylketonuric children].
    Yuan L; Fang B; Wang M; Wang T; Huang S; Yang T; Zhao S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Oct; 15(5):297-9. PubMed ID: 9758878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of phenylketonuria alleles in the Italian population.
    Dianzani I; Giannattasio S; de Sanctis L; Alliaudi C; Lattanzio P; Dionisi Vici C; Burlina A; Burroni M; Sebastio G; Carnevale F
    Eur J Hum Genet; 1995; 3(5):294-302. PubMed ID: 8556304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational study of missense mutations in phenylalanine hydroxylase.
    Réblová K; Kulhánek P; Fajkusová L
    J Mol Model; 2015 Apr; 21(4):70. PubMed ID: 25750018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gestational carrier--a reproductive haven for offspring of mothers with phenylketonuria (PKU): an alternative therapy for maternal PKU.
    Fisch RO; Tagatz G; Stassart JP
    J Inherit Metab Dis; 1993; 16(6):957-61. PubMed ID: 8127071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenylketonuria in Italy: distinct distribution pattern of three mutations of the phenylalanine hydroxylase gene.
    Guzzetta V; Bonapace G; Dianzani I; Parenti G; Lecora M; Giannattasio S; Concolino D; Strisciuglio P; Sebastio G; Andria G
    J Inherit Metab Dis; 1997 Sep; 20(5):619-24. PubMed ID: 9323556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship among genotype, biochemical phenotype, and cognitive performance in females with phenylalanine hydroxylase deficiency: report from the Maternal Phenylketonuria Collaborative Study.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 1999 Aug; 104(2 Pt 1):258-62. PubMed ID: 10429004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Chinese family with phenylketonuria and maternal phenylketonuria detected by family screening.
    Hsiao KJ; Chen CH; Chiu PC; Huang SC; Wuu KD
    Eur J Pediatr; 1986 Oct; 145(5):409-12. PubMed ID: 3792388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenylketonuria genotypes correlated to metabolic phenotype groups in Norway.
    Eiken HG; Knappskog PM; Motzfeldt K; Boman H; Apold J
    Eur J Pediatr; 1996 Jul; 155(7):554-60. PubMed ID: 8831077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterozygote advantage for the phenylketonuria allele.
    Smith I; Carter CO; Wolff OH
    J Med Genet; 1978 Jun; 15(3):246-8. PubMed ID: 671494
    [No Abstract]   [Full Text] [Related]  

  • 31. [Mutation of the phenylalanine hydroxylase gene in the population of central Bohemia. Relation to the clinical picture of phenylketonuria].
    Růzicková S; Kozák L; Blazková M; Kapras J; St'astná S
    Cas Lek Cesk; 1997 May; 136(9):282-5. PubMed ID: 9264877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
    Trefz FK; Blau N
    Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consanguineous marriages in families suffering from phenylketonuria.
    Blyumina MG
    Sov Genet; 1974 Nov; 9(1):112-4. PubMed ID: 4281514
    [No Abstract]   [Full Text] [Related]  

  • 34. DHPLC mutation analysis of phenylketonuria.
    Bräutigam S; Kujat A; Kirst P; Seidel J; Lüleyap HU; Froster UG
    Mol Genet Metab; 2003 Mar; 78(3):205-10. PubMed ID: 12649065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical consequences of heterozygosity for autosomal-recessive diseases.
    Vogel F
    Clin Genet; 1984 May; 25(5):381-415. PubMed ID: 6373070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Phenylketonuria as a model system for DNA diagnosis of hereditary disorders].
    Meijer H; Hekking M; van den Enden AT; Jongbloed RJ; Schrander-Stumpel CT; Geraedts JP
    Ned Tijdschr Geneeskd; 1990 Oct; 134(40):1954-8. PubMed ID: 1978255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of PAH genotype-based predictions of metabolic phenylalanine hydroxylase deficiency phenotype: investigation of PKU/MHP patients from Lithuania.
    Kasnauskiene J; Cimbalistiene L; Kucinskas V
    Med Sci Monit; 2003 Mar; 9(3):CR142-6. PubMed ID: 12640344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current problems of juvenile feeblemindedness].
    Steinkopff E
    Z Arztl Fortbild (Jena); 1966 Sep; 60(17):989-94. PubMed ID: 4231816
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of medical genetics concerning phenylketonuria: accomplishments, status and practical future possibilities.
    Güttler F
    Clin Genet; 1989 Nov; 36(5):333-4. PubMed ID: 2598484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [An eighteen-year study on phenylketonuria].
    Yu WM; Xu L; Li XW; He C; Shen M; Zhang ZX; Jin YY; Zhou ZS; Qiao F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):218-22. PubMed ID: 12905726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.